Search Results - "Health Services Accessibility/economics"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Source: Lancet Glob Health
    Burton, M J, Ramke, J, Marques, A P, Bourne, R R A, Congdon, N, Jones, I, Ah Tong, B A M, Arunga, S, Bachani, D, Bascaran, C, Bastawrous, A, Blanchet, K, Braithwaite, T, Buchan, J C, Cairns, J, Cama, A, Chagunda, M, Chuluunkhuu, C, Cooper, A, Crofts-Lawrence, J, Dean, W H, Denniston, A K, Ehrlich, J R, Emerson, P M, Evans, J R, Frick, K D, Friedman, D S, Furtado, J M, Gichangi, M M, Gichuhi, S, Gilbert, S S, Gurung, R, Habtamu, E, Holland, P, Jonas, J B, Keane, P A, Keay, L, Khanna, R C, Khaw, P T, Kuper, H, Kyari, F, Lansingh, V C, Mactaggart, I, Mafwiri, M M, Mathenge, W, McCormick, I, Morjaria, P, Mowatt, L, Muirhead, D, Murthy, G V S, Mwangi, N, Patel, D B, Peto, T, Qureshi, B M, Salomão, S R, Sarah, V, Shilio, B R, Solomon, A W, Swenor, B K, Taylor, H R, Wang, N, Webson, A, West, S K, Wong, T Y, Wormald, R, Yasmin, S, Yusufu, M, Silva, J C, Resnikoff, S, Ravilla, T, Gilbert, C E, Foster, A & Faal, H B 2021, 'The Lancet Global Health Commission on Global Eye Health: vision beyond 2020', The Lancet. Global health, vol. 9, no. 4, pp. e489-e551. https://doi.org/10.1016/S2214-109X(20)30488-5

    Subject Terms: Eye Diseases / epidemiology, Radiology, Nuclear Medicine and Imaging, Blindness / etiology, Eye Diseases, Epidemiology, FOS: Political science, European union, International trade, FOS: Health sciences, Global Health, Blindness, European commission, Health Services Accessibility, Global Burden of Disease, Detection and Management of Retinal Diseases, 0302 clinical medicine, Cost of Illness, Global Epidemiology of Myopia and Visual Impairment, 11. Sustainability, Business, 10. No inequality, Political science, Psychiatry, Quality of Health Care / organization & administration, Quality of life (healthcare), Blindness/economics, Eye Diseases / therapy, 4. Education, 1. No poverty, Commission, Sustainable Development, Health Services Accessibility / organization & administration, 3. Good health, Quality of Health Care/economics, Health Services Accessibility/economics, Global Burden of Disease/economics, Eye care, Medicine, Blindness / prevention & control, Blindness / economics, Health Services Accessibility / economics, Advisory Committees / organization & administration, Advisory Committees/organization & administration, Global Burden of Disease / economics, Advisory Committees, Global health, FOS: Law, Nursing, Quality of Health Care / economics, 12. Responsible consumption, Eye Diseases/complications, 03 medical and health sciences, Health Sciences, Humans, Quality of Health Care, Eye Diseases / complications, Ocular Manifestations of COVID-19, Health care, Visual impairment, Ophthalmology, The Lancet Global Health Commission, Eye Diseases / diagnosis, Quality of Life, Visual Impairment, Law, Optometry

    File Description: application/pdf

  6. 6

    Source: Kamath, S, Poojary, M, Shetty, H, Umesh, K, Kar, S, Lakshmi Ramesh, V, Hajare, G, Thomas, A, Brand, H, Jahangir, S & Kamath, R 2024, '"Private Hospitals Generally Offer Better Treatment and Facilities" : Out-of-Pocket Expenditure on Healthcare and the Preference for Private Healthcare Providers in South India', International Journal of Environmental Research and Public Health, vol. 21, no. 10, 1287. https://doi.org/10.3390/ijerph21101287

    Relation: info:eu-repo/semantics/altIdentifier/pissn/1660-4601

  7. 7

    Source: Lancet Oncol

    File Description: application/pdf

  8. 8
  9. 9
  10. 10

    Source: Preventive Medicine, Vol. 99 (2017) pp. 37-42

  11. 11

    Source: RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
    instname
    Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, J J, Nathan, P, Dummer, R, Forsea, A M, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, G K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M & Garbe, C 2017, ' More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments ', European Journal of Cancer, vol. 75, pp. 313-322 . https://doi.org/10.1016/j.ejca.2017.01.012

    Subject Terms: Human development index, Male, Cancer Research, Skin Neoplasms, Survival, Access, Health expenditure per capita, Immunooncology, Innovative medicines, Metastatic melanoma, Targeted therapy, Treatment, Acrylonitrile, Aniline Compounds, Antibodies, Monoclonal, Humanized, Europe, Female, Health Services Accessibility, Healthcare Disparities, Humans, Immunotherapy, Melanoma, Programmed Cell Death 1 Receptor, Proto-Oncogene Proteins B-raf, Reimbursement Mechanisms, Therapies, Investigational, Oncology, Melanoma/economics, Reimbursement Mechanism, Disparities, Immuno oncology, Medicines, access, 0302 clinical medicine, Monoclonal, Diagnosis, Humanized/economics, Healthcare Disparities/economics, Acrylonitrile/analogs & derivatives, Acce, Proto-Oncogene Proteins B-raf/antagonists & inhibitors, treatment, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Aniline Compound, 3. Good health, Health Services Accessibility/economics, Healthcare Disparitie, Innovative medicine, Health-care, innovative medicines, metastatic melanoma, Human, Reimbursement Mechanisms/statistics & numerical data, Union, Antibodies, Europe/epidemiology, Malignant-melanoma, 03 medical and health sciences, Skin Neoplasm, Mortality, Therapies, Investigational/economics, Skin Neoplasms/economics, Investigational/economics, immunooncologytargeted therapyhealth expenditure per capita, human development index, Reimbursement, Immunotherapy/economics, Therapies, Aniline Compounds/economics, Cancer incidence, Antibodies, Monoclonal, Humanized/economics

    File Description: application/pdf; text

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20